These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 27978522)
1. Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin. Konturek PC; Haziri D; Helfritzsch H; Hess T; Harsch IA Med Princ Pract; 2017; 26(2):182-184. PubMed ID: 27978522 [TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent and severe Clostridium difficile infection. Keller JJ; Kuijper EJ Annu Rev Med; 2015; 66():373-86. PubMed ID: 25587656 [TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease. Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071 [TBL] [Abstract][Full Text] [Related]
5. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107 [TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit. Han S; Shannahan S; Pellish R J Intensive Care Med; 2016 Oct; 31(9):577-86. PubMed ID: 26141116 [TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. Rao K; Safdar N J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412 [TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France. Baro E; Galperine T; Denies F; Lannoy D; Lenne X; Odou P; Guery B; Dervaux B PLoS One; 2017; 12(1):e0170258. PubMed ID: 28103289 [TBL] [Abstract][Full Text] [Related]
9. Recurrent Song JH; Kim YS Gut Liver; 2019 Jan; 13(1):16-24. PubMed ID: 30400734 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection in older adults: a review and update on its management. Kee VR Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856 [TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications. Shaukat A; Reinink AR Am Fam Physician; 2017 Mar; 95(6):351-352. PubMed ID: 28318210 [No Abstract] [Full Text] [Related]
12. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series. Hefazi M; Patnaik MM; Hogan WJ; Litzow MR; Pardi DS; Khanna S Mayo Clin Proc; 2017 Nov; 92(11):1617-1624. PubMed ID: 29101931 [TBL] [Abstract][Full Text] [Related]
13. Fidaxomicin and Fecal Microbiota Transplants for Severe Clostridium difficile Colitis. Mankal PK; Abed J; Latte-Naor S; Grinspan A; Kotler DP Am J Ther; 2019; 26(1):e115-e117. PubMed ID: 30601771 [No Abstract] [Full Text] [Related]
16. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Hvas CL; Dahl Jørgensen SM; Jørgensen SP; Storgaard M; Lemming L; Hansen MM; Erikstrup C; Dahlerup JF Gastroenterology; 2019 Apr; 156(5):1324-1332.e3. PubMed ID: 30610862 [TBL] [Abstract][Full Text] [Related]
17. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460 [TBL] [Abstract][Full Text] [Related]
18. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. Cornely OA; Nathwani D; Ivanescu C; Odufowora-Sita O; Retsa P; Odeyemi IA J Antimicrob Chemother; 2014 Nov; 69(11):2892-900. PubMed ID: 25074856 [TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. Kelly CR; de Leon L; Jasutkar N J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]